Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples